journal article·2015-09

Temporally Tunable, Enzymatically Responsive Delivery of Proangiogenic Peptides from Poly(ethylene glycol) Hydrogels

Amy H. Van Hove, Erin Antonienko, Kathleen Burke, Edward Brown, Danielle S. W. Benoit

Advanced Healthcare Materials· Volume 4· Issue 13
Publisher page

Abstract

Proangiogenic drugs hold great potential to promote reperfusion of ischemic tissues and in tissue engineering applications, but efficacy is limited by poor targeting and short half‐lives. Methods to control release duration or provide enzymatically responsive drug delivery have independently improved drug efficacy. However, no material has been developed to temporally control the rate of enzymatically responsive drug release. To address this void, hydrogels are developed to provide sustained, tunable release of Qk, a proangiogenic peptide mimic of vascular endothelial growth factor, via tissue‐specific enzymatic activity. After confirmation that sustained delivery of Qk is necessary for proangiogenic effects, a variety of previously identified matrix metalloproteinase (MMP)‐degradable linkers are used to tether Qk to hydrogels. Of these, three (IPES↓LRAG, GPQG↓IWGQ, and VPLS↓LYSG) show MMP‐responsive peptide release. These linkers provide tunable Qk release kinetics, with rates ranging from 1.64 to 19.9 × 10−3 h−1 in vitro and 4.82 to 8.94 × 10−3 h−1 in vivo. While Qk is confirmed to be bioactive as released, hydrogels releasing Qk fail to induce significant vascularization in vivo after one week, likely due to the use of nonenzymatically degradable hydrogels. While Qk is the focus of this study, the approach could easily be adapted to control the delivery of a variety of therapeutic molecules.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Protease and Inhibitor Mechanisms · Peptidase Inhibition and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering 207 Robert B. Goergen Hall University of Rochester Rochester NY 14627 USA

Department of Neurobiology and Anatomy University of Rochester 601 Elmwood Ave Rochester NY 14642 USA

Department of Biomedical Genetics 601 Elmwood Ave University of Rochester Rochester NY 14642 USA

Department of Chemical Engineering 206 Gavett Hall University of Rochester Rochester NY 14627 USA

Center for Musculoskeletal Research 601 Elmwood Ave University of Rochester Medical Center Rochester NY 14642 USA

Funding

Howard Hughes Medical Institute Med-into-Grad fellowship (A.H.V.H.) · National Institute of Health · Department of Defense

References (55)

Show source-provided references
1. 10.1136/hrt.2009.18041410.1136/hrt.2009.180414 ↗
2. 10.1089/ten.teb.2009.008510.1089/ten.teb.2009.0085 ↗
3. 10.1016/j.biomaterials.2009.10.05210.1016/j.biomaterials.2009.10.052 ↗
4. 10.1111/j.1538-7836.2007.02386.x10.1111/j.1538-7836.2007.02386.x ↗
5. 10.1016/j.bcp.2012.04.01110.1016/j.bcp.2012.04.011 ↗
6. 10.1186/1479-5876-7-4110.1186/1479-5876-7-41 ↗
7. 10.1073/pnas.050504710210.1073/pnas.0505047102 ↗
8. 10.1111/cbdd.1205510.1111/cbdd.12055 ↗
9. Laham R. J. · Drug Metab. Dispos. · 1999 · 27 · 82110.1016/S0090-9556(24)11823-5 ↗
10. 10.1073/pnas.090544710710.1073/pnas.0905447107 ↗
11. 10.1096/fj.02-1041fje10.1096/fj.02-1041fje ↗
12. 10.1016/j.jconrel.2010.07.09710.1016/j.jconrel.2010.07.097 ↗
13. 10.1007/s11095-005-5644-210.1007/s11095-005-5644-2 ↗
14. 10.1172/JCI1842010.1172/JCI18420 ↗
15. 10.1006/excr.1998.435910.1006/excr.1998.4359 ↗
16. 10.1016/0092-8674(95)90401-810.1016/0092-8674(95)90401-8 ↗
17. 10.1016/S0002-9440(10)64242-310.1016/S0002-9440(10)64242-3 ↗
18. 10.1016/j.biomaterials.2010.06.06110.1016/j.biomaterials.2010.06.061 ↗
19. 10.1016/j.biomaterials.2013.09.02010.1016/j.biomaterials.2013.09.020 ↗
20. 10.1021/bm300752j10.1021/bm300752j ↗
21. 10.1016/j.biomaterials.2014.08.01910.1016/j.biomaterials.2014.08.019 ↗
22. 10.1093/nar/gks41910.1093/nar/gks419 ↗
23. 10.1093/protein/gzh09710.1093/protein/gzh097 ↗
24. 10.1163/15685620074410110.1163/156856200744101 ↗
25. 10.1016/j.biomaterials.2010.08.09110.1016/j.biomaterials.2010.08.091 ↗
26. 10.1016/j.actbio.2014.04.01210.1016/j.actbio.2014.04.012 ↗
27. 10.1016/j.biomaterials.2011.05.07810.1016/j.biomaterials.2011.05.078 ↗
28. 10.1088/1748-6041/1/1/R0110.1088/1748-6041/1/1/R01 ↗
29. 10.1161/ATVBAHA.113.30116410.1161/ATVBAHA.113.301164 ↗
30. 10.1016/j.biomaterials.2010.01.01410.1016/j.biomaterials.2010.01.014 ↗
31. 10.1016/S0022-4804(02)00034-310.1016/S0022-4804(02)00034-3 ↗
32. 10.1016/S0828-282X(07)70818-810.1016/S0828-282X(07)70818-8 ↗
33. 10.1016/j.biomaterials.2006.07.00410.1016/j.biomaterials.2006.07.004 ↗
34. 10.1038/9027310.1038/90273 ↗
35. 10.1016/j.semcancer.2005.05.00410.1016/j.semcancer.2005.05.004 ↗
36. 10.1002/jbm.a.3077110.1002/jbm.a.30771 ↗
37. 10.1016/S0142-9612(00)00120-410.1016/S0142-9612(00)00120-4 ↗
38. 10.1002/jbm.a.2009110.1002/jbm.a.20091 ↗
39. 10.1163/15685620878490943510.1163/156856208784909435 ↗
40. 10.1074/jbc.271.48.3051710.1074/jbc.271.48.30517 ↗
41. Yang L. L. · Cancer Res. · 2003 · 63 · 831
42. 10.1021/jm058249k10.1021/jm058249k ↗
43. 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B ↗
44. 10.1002/term.9510.1002/term.95 ↗
45. 10.1002/pro.225310.1002/pro.2253 ↗
46. 10.1038/nprot.2010.610.1038/nprot.2010.6 ↗
47. 10.1109/TMI.2004.83733910.1109/TMI.2004.837339 ↗
48. 10.1002/adma.20090180810.1002/adma.200901808 ↗
49. 10.1016/j.biomaterials.2009.08.05510.1016/j.biomaterials.2009.08.055 ↗
50. 10.1002/ijc.2574310.1002/ijc.25743 ↗
51. 10.1016/S0002-9440(10)64276-910.1016/S0002-9440(10)64276-9 ↗
52. 10.1016/j.jconrel.2004.07.01810.1016/j.jconrel.2004.07.018 ↗
53. 10.1023/A:100711440495310.1023/A:1007114404953 ↗
54. 10.1006/mvre.1997.204710.1006/mvre.1997.2047 ↗
55. 10.1007/s00011-004-1299-410.1007/s00011-004-1299-4 ↗